Saturday, October 04, 2014 8:29:55 PM
Yes, NNVC's technology does sound almost too good to be true, which is why so many are so excited about its potential.
It's good to be skeptical as well, if there were some solid facts about the science to support the skepticism. So far the main argument against this company is - they haven't done it yet, and it's taking much longer than predicted, so it will never happen ... or I don't like management, they seem shady to me, or worse yet - somebody who didn't like my pet stock likes this stock, so therefore I must not like his stock... this is all juvenile BS.
It's also good to expect management to communicate well, and to do a little better about predicting timelines, so that is constructive criticism, and well-deserved in this case.
Anyways, yes everyone has an opinion, and the collective opinion of investors is what determines the market cap. Right now, NNVC hasn't shown enough for investors to really buy the story. It remains a great story, if they can start to deliver. I agree that right now, they haven't delivered all that much, just slow and steady progress towards their goals - getting the cides into humans to show they are safe and effective. What's one more year to wait for this incredible potential?
It's good to be skeptical as well, if there were some solid facts about the science to support the skepticism. So far the main argument against this company is - they haven't done it yet, and it's taking much longer than predicted, so it will never happen ... or I don't like management, they seem shady to me, or worse yet - somebody who didn't like my pet stock likes this stock, so therefore I must not like his stock... this is all juvenile BS.
It's also good to expect management to communicate well, and to do a little better about predicting timelines, so that is constructive criticism, and well-deserved in this case.
Anyways, yes everyone has an opinion, and the collective opinion of investors is what determines the market cap. Right now, NNVC hasn't shown enough for investors to really buy the story. It remains a great story, if they can start to deliver. I agree that right now, they haven't delivered all that much, just slow and steady progress towards their goals - getting the cides into humans to show they are safe and effective. What's one more year to wait for this incredible potential?
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
